BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9154590)

  • 1. Nursing home research from industry's perspective.
    Brecher M
    Int Psychogeriatr; 1996; 8 Suppl 3():367-70. PubMed ID: 9154590
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing home research from investigators' perspective.
    Finkel SI; Lyons J
    Int Psychogeriatr; 1996; 8 Suppl 3():371-3; discussion 381-2. PubMed ID: 9154591
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral symptoms in dementia: community-based research.
    Auer SR; Monteiro IM; Reisberg B
    Int Psychogeriatr; 1996; 8 Suppl 3():363-6; discussion 381-2. PubMed ID: 9154589
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of controlled pharmacologic trials.
    Schneider LS
    Int Psychogeriatr; 1996; 8 Suppl 3():375-9; discussion 381-2. PubMed ID: 9154592
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotic treatment in outpatients with dementia.
    Devanand DP
    Int Psychogeriatr; 1996; 8 Suppl 3():355-61; discussion 381-2. PubMed ID: 9154588
    [No Abstract]   [Full Text] [Related]  

  • 6. Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia.
    Martin-Cook K; Hynan LS; Rice-Koch K; Svetlik DA; Weiner MF
    Dement Geriatr Cogn Disord; 2005; 19(2-3):82-5. PubMed ID: 15572876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating behavioral disturbances of dementia from drug side effects.
    Eastham JH; Jeste DV
    Int Psychogeriatr; 1996; 8 Suppl 3():429-34; discussion 447-8. PubMed ID: 9154602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
    MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
    [No Abstract]   [Full Text] [Related]  

  • 9. Hallucinations.
    Whitehouse PJ; Patterson MB; Strauss ME; Geldmacher DS; Mack JL; Gilmore GC; Koss E
    Int Psychogeriatr; 1996; 8 Suppl 3():387-92. PubMed ID: 9154594
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral disturbances of dementia in the nursing home.
    Rovner BW
    Int Psychogeriatr; 1996; 8 Suppl 3():435-7. PubMed ID: 9154603
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care.
    Lövheim H; Sandman PO; Kallin K; Karlsson S; Gustafson Y
    Int Psychogeriatr; 2006 Dec; 18(4):713-26. PubMed ID: 16879762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delusions.
    Trabucchi M; Bianchetti A
    Int Psychogeriatr; 1996; 8 Suppl 3():383-5; discussion 423-4. PubMed ID: 9154593
    [No Abstract]   [Full Text] [Related]  

  • 13. CERAD behavior rating scale for dementia.
    Tariot PN
    Int Psychogeriatr; 1996; 8 Suppl 3():317-20; discussion 351-4. PubMed ID: 9154581
    [No Abstract]   [Full Text] [Related]  

  • 14. Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
    Lane HY; Chang YC; Su MH; Chiu CC; Huang MC; Chang WH
    J Clin Psychopharmacol; 2002 Feb; 22(1):4-10. PubMed ID: 11799336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.
    Rabinowitz J; Davidson M; De Deyn PP; Katz I; Brodaty H; Cohen-Mansfield J
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):991-8. PubMed ID: 16286443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone in the treatment of delusions of infestation.
    De León OA; Furmaga KM; Canterbury AL; Bailey LG
    Int J Psychiatry Med; 1997; 27(4):403-9. PubMed ID: 9565735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.
    Kleijer BC; van Marum RJ; Frijters DH; Jansen PA; Ribbe MW; Egberts AC; Heerdink ER
    Int Psychogeriatr; 2014 Mar; 26(3):363-71. PubMed ID: 24252349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
    Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
    J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial.
    Mintzer J; Greenspan A; Caers I; Van Hove I; Kushner S; Weiner M; Gharabawi G; Schneider LS
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):280-91. PubMed ID: 16505133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.